Optomed Oyj Balance Sheet Health
Financial Health criteria checks 6/6
Optomed Oyj has a total shareholder equity of €20.4M and total debt of €3.4M, which brings its debt-to-equity ratio to 16.5%. Its total assets and total liabilities are €29.1M and €8.7M respectively.
Key information
16.5%
Debt to equity ratio
€3.35m
Debt
| Interest coverage ratio | n/a |
| Cash | €7.12m |
| Equity | €20.36m |
| Total liabilities | €8.72m |
| Total assets | €29.08m |
Recent financial health updates
Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?
Aug 05Recent updates
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost
Mar 22Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 18Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues
Dec 21Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Aug 09Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)
Jun 01Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?
Aug 05The Optomed Oyj (HEL:OPTOMED) Share Price Has Gained 14% And Shareholders Are Hoping For More
Feb 16Financial Position Analysis
Short Term Liabilities: OPTOMED's short term assets (€13.1M) exceed its short term liabilities (€5.1M).
Long Term Liabilities: OPTOMED's short term assets (€13.1M) exceed its long term liabilities (€3.7M).
Debt to Equity History and Analysis
Debt Level: OPTOMED has more cash than its total debt.
Reducing Debt: OPTOMED's debt to equity ratio has reduced from 196.3% to 16.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OPTOMED has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OPTOMED has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 13.6% each year.